Inhibrx Biosciences

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$10.80-$37.53
Market Cap
$486.8M
Shares Short
721,500

Financials

See more
Revenue (12 Mos)
$1.4M
Revenue Growth (YoY)
1,200%
Gross Profit (12 Mos)
-$171.7M
Diluted EPS
-$16.57

News

See more

Yahoo Finance • 2 months ago

Countdown To October: Inhibrx Awaits Ozekibart Clinical Data

Yahoo Finance • 2 months ago

Inhibrx Biosciences GAAP EPS of -$1.85, revenue of $1.3M

Yahoo Finance • 3 months ago

Noteworthy Tuesday Option Activity: INBX, ODP, AZO

Yahoo Finance • 2 years ago

Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials

About

CEO
Mr. Mark Paul Lappe
CFO
Ms. Kelly Devine Deck B.S., CPA, M.S.
Address
11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
156